Aylin A Demirer (Aylin Alasonyalilar Demirer, Aylin Alasonyalilar-Demirer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Radical Prostatectomy

Top Venues

Molecular cancer therapeutics

bioRxiv : the preprint server for biology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Adam M Kase, Justyna Joanna Gleba, James L Miller, Erin Miller, Joachim L Petit, Michael T Barrett, Yumei Zhou, Ephraim E Parent, Hancheng Cai, Joshua A Knight, Jacob J Orme, Jordan P Reynolds, William F Durham, Thomas M Metz, Nathalie Meurice, Brandy Edenfield, Aylin A Demirer, Ahmet Bilgili, Peyton G Hickman, Matthew L Pawlush, Laura Marlow, Daniel P Wickland, Winston Tan, John A Copland Iii
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 23 (6) (2024)
Adam M Kase, Justyna Joanna Gleba, James L Miller, Erin Miller, Joachim L Petit, Michael T Barrett, Yumei Zhou, Ephraim E Parent, Hancheng Cai, Joshua A Knight, Jacob J Orme, Jordan P Reynolds, William F Durham, Thomas M Metz, Nathalie Meurice, Brandy Edenfield, Aylin A Demirer, Ahmet Bilgili, Peyton G Hickman, Matthew L Pawlush, Laura Marlow, Daniel P Wickland, Winston Tan, John A Copland Iii
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 23 (6) (2024)
Jason Shirian, Alexandra Hockla, Justyna Joanna Gleba, Mathew A Coban, Naama Rotenberg, Laura M Strik, Aylin A Demirer, Matt L Pawlush, John A Copland Iii, Evette S Radisky, Julia M Shifman
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension. bioRxiv : the preprint server for biology (2024)
Jason Shirian, Alexandra Hockla, Justyna Joanna Gleba, Mathew A Coban, Naama Rotenberg, Laura M Strik, Aylin A Demirer, Matt L Pawlush, John A Copland Iii, Evette S Radisky, Julia M Shifman
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension. bioRxiv : the preprint server for biology (2024)
Adam M Kase, Justyna Joanna Gleba, James L Miller, Erin Miller, Joachim L Petit, Michael T Barrett, Yumei Zhou, Ephraim E Parent, Hancheng Cai, Joshua A Knight, Jacob J Orme, Jordan P Reynolds, William F Durham, Thomas M Metz, Nathalie Meurice, Brandy Edenfield, Aylin A Demirer, Ahmet Bilgili, Peyton G Hickman, Matthew L Pawlush, Laura Marlow, Daniel P Wickland, Winston Tan, John A Copland Iii
Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer. Molecular cancer therapeutics (2024)
Said M Elshafae, Wessel P Dirksen, Aylin A Demirer, Justin Breitbach, Shiyu Yuan, Noriko Kantake, Wachiraphan Supsavhad, Bardes B Hassan, Zayed Attia, Lucas B Alstadt, Thomas J Rosol
Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis. The Prostate 80 (9) (2020)
Nicole A Kohart, Said M Elshafae, Aylin A Demirer, Wessel P Dirksen, Justin T Breitbach, Sherry T Shu, Jingyu Xiang, Katherine N Weilbaecher, Thomas J Rosol
Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors. Leukemia & lymphoma 61 (2) (2019)